AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 11122797
Drug: Anthracyclines, platinum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anthracyclines, platinum compounds, and paclitaxel
Trial: 11122797
Drug: Immunohistochemical determination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immunohistochemical determination of tumor receptor status
Trial: 11122797
Drug: Anti-HER2/neu monoclonal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anti-HER2/neu monoclonal antibody
Trial: 8669350
Drug: Conventional discharge
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional discharge (CD) preparation
Trial: 683909
Drug: Extra potassium
RxNorm normalized name: Panadol Extra
DrugBank: Acetaminophen (DB00316)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extra potassium supplements
Trial: 27001804
Drug: Single oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single oral dose of PXVX0200 (approximately 5 × 10(8) CFU)
Trial: 20829597
Drug: Herbal medicine
RxNorm normalized name: Herbal medicine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Herbal medicine Daikenchuto (TJ‐100; 5.0 g) with distilled water (Group B)
Trial: 17079360
Drug: Goldenseal (3210
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Goldenseal (3210 mg daily for 14 days)
Trial: 17079360
Drug: Kava kava
RxNorm normalized name: Kava kava
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Kava kava (1227 mg daily for 14 days)
Trial: 16221754
Drug: Rifampin (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rifampin (600 mg daily for 7 days)
Trial: 16221754
Drug: Clarithromycin (1000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clarithromycin (1000 mg daily for 7 days)
Trial: 16244024
Drug: Continuous epidural
RxNorm normalized name: ACCU-BLOC PERIFIX CONTINUOUS EPIDURAL ANESTHESIA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous epidural infusion via 2 epidural catheters for postoperative analgesia (group E)
Trial: 16244024
Drug: Intraoperative general
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraoperative general anesthesia and postoperative IV morphine analgesia (group G)
Trial: 12107602
Drug: valsartan 80
RxNorm normalized name: valsartan 80 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: valsartan 80 mg daily
Trial: 10338217
Drug: Oral glutamine
RxNorm normalized name: Glutamine
DrugBank: L-Glutamine (DB00130)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral glutamine (GLN) 10 g three times daily
Trial: 10338217
Drug: Glycine-control (GLY)
RxNorm normalized name: Glycine
DrugBank: Glycine (DB00145)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Glycine-control (GLY) 10 g three times daily
Trial: 10338217
Drug: Oral glutamine
RxNorm normalized name: Glutamine
DrugBank: L-Glutamine (DB00130)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral glutamine (GLN)
Trial: 10338217
Drug: Oral and
RxNorm normalized name: Tridate, oral and rectal kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral and parenteral glutamine (GLN)
Trial: 8747034
Drug: Naltrexone 50
RxNorm normalized name: naltrexone 50 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naltrexone 50 mg/day for 6 months
Trial: 1903079
Drug: Dihydroergocryptine (DEK)
DrugBank: Dihydroergocryptine (DB13385)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dihydroergocryptine (DEK) at mean daily doses of approximately 40 mg (ranging from 15 to 60 mg)
Trial: 7381028
Drug: Sulfinpyrazone (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sulfinpyrazone (200 mg orally three times a day)
Trial: 19540659
Drug: Low intensity
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low intensity pulsed ultrasound (LIPUS) treatment
Trial: 17440643
Drug: Losartan (L)
DrugBank: Losartan (DB00678)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Losartan (L) 50 mg plus Hydrochlorothiazide (HCTZ) 12.5 mg titrated to L 100 mg plus HCTZ 25 mg
Trial: 17440643
Drug: Losartan (L)
DrugBank: Losartan (DB00678)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Losartan (L) and Hydrochlorothiazide (HCTZ)
Trial: 17440643
Drug: Stepped-care (HCTZ
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stepped-care (HCTZ 12.5 mg plus Atenolol 50 mg)
Trial: 15239726
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of tryptase and histamine measurements
Trial: 8250765
Drug: Buserelin (900
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buserelin (900 micrograms/d administered intranasally)
Trial: 8250765
Drug: Danazol (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Danazol (400 mg/d p.o.)
Trial: 3533825
Drug: Bendroflumethiazide (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bendroflumethiazide (2.5 mg) + 573 mg potassium chloride 3 times a day
Trial: 31788880
Drug: nano-curcumin (80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: nano-curcumin (80 mg daily for 8 weeks)
Trial: 27694598
Drug: Operative treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Operative treatment for type III fractures
Trial: 22189524
Drug: Clindamycin or
RxNorm normalized name: clindamycin Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clindamycin or first-generation cephalosporin (IV for 2-4 days, then oral)
Trial: 20965458
Drug: Overnight hospitalization
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Overnight hospitalization with 12-hour abciximab infusion
Trial: 30789515
Drug: Sequential application
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sequential application of 1,450-nm diode laser and 450-nm blue light
Trial: 28301865
Drug: Manual therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Manual therapy and static ultrasound
Trial: 28301865
Drug: Manual therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Manual therapy and diadynamic currents
Trial: 20551220
Drug: Varenicline (0.25,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Varenicline (0.25, 0.5, 1.0, 2.0 mg)
Trial: 20551220
Drug: Varenicline (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Varenicline (0.5 or 1.0 mg) twice daily
Trial: 17255304
Drug: Sorafenib (in
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sorafenib (in combination with IFN, bevacizumab, or temsirolimus)
Trial: 15124757
Drug: IFNbeta‐1a 30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IFNbeta‐1a 30 mcg IM once weekly
Trial: 15124757
Drug: IFNbeta‐1a 60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IFNbeta‐1a 60 mcg IM once weekly
Trial: 15124757
Drug: Both doses
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both doses of IFNbeta‐1a
Trial: 11697022
Drug: Allicin-containing garlic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Allicin-containing garlic supplement, one capsule daily for 12 weeks
Trial: 7898227
Drug: LDL apheresis
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LDL apheresis plus simvastatin 40 mg daily
Trial: 7898227
Drug: Colestipol 20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Colestipol 20 g plus simvastatin 40 mg daily
Trial: 2803775
Drug: Topical fusidic
RxNorm normalized name: fusidate Topical Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical fusidic acid 1%
Trial: 2803775
Drug: Topical chloramphenicol
RxNorm normalized name: chloramphenicol Topical Ointment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical chloramphenicol 0.5%
Trial: 1100301
Drug: Penfluridol (30,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Penfluridol (30, 60, and 120 mg weekly)
Trial: 28255102
Drug: Triple-Antiplatelet Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple-Antiplatelet Therapy (TAPT) with cilostazol
Trial: 28255102
Drug: Dual-Antiplatelet Therapy
RxNorm normalized name: Tums Dual Action
DrugBank: Alginic acid (DB13518)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dual-Antiplatelet Therapy (DAPT) (aspirin and clopidogrel)
Trial: 23414490
Drug: IL-6 -174
RxNorm normalized name: IL-6
DrugBank: Human interleukin-6 (DB15060)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IL-6 -174 CC genotype
Trial: 17071020
Drug: Bi-weekly judicial
RxNorm normalized name: selinexor
DrugBank: Selinexor (DB11942)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Bi-weekly judicial status hearings
Trial: 26051110
Drug: Weekly 35
RxNorm normalized name: norelgestromin
DrugBank: Norelgestromin (DB06713)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Weekly 35 mg risedronate
Trial: 26051110
Drug: Daily 5
RxNorm normalized name: Walgreens Gold Seal One Daily 50 Plus Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily 5 mg risedronate
Trial: 23677653
Drug: Daily injections
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily injections of filgrastim (100 μg/m(2))
Trial: 23677653
Drug: DA‐3031 3.6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DA‐3031 3.6 mg
Trial: 23677653
Drug: DA‐3031 6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DA‐3031 6 mg
Trial: 21596879
Drug: Fospropofol IV
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fospropofol IV infusion with a bolus and increased infusion rate for agitation events (infusion/bolus)
Trial: 21596879
Drug: Fospropofol IV
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fospropofol IV infusion with an increased infusion rate for agitation events (infusion only)
Trial: 21596879
Drug: Propofol IV
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propofol IV infusion with an increased infusion rate for agitation events
Trial: 12780882
Drug: Open treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Open treatment alone (Open Group)
Trial: 8883120
Drug: Daily oral
RxNorm normalized name: GEMTESA 75 MG Once-Daily Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily oral alendronate
Trial: 1595914
Drug: Intraarticular morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraarticular morphine (0.03%, with or without 1:200,000 epinephrine)
Trial: 27209505
Drug: Cisplatin (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisplatin (100 mg/m2) or Cisplatin (75 mg/m2) plus Tirapazamine with concurrent radiation therapy (70 Gy over 7 weeks)
Trial: 24638013
Drug: Erlotinib 150
RxNorm normalized name: erlotinib 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erlotinib 150 mg for 1 year
Trial: 7912725
Drug: Taxotere (docetaxel)
RxNorm normalized name: Docetaxel
DrugBank: Docetaxel (DB01248)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Taxotere (docetaxel) at 110 mg/m2 per course
Trial: 2319479
Drug: Caffeine 100
RxNorm normalized name: caffeine 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeine 100 mg
Trial: 31222342
Drug: Methionine requirements
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methionine requirements expressed as g/MJ ME of diet
Trial: 22692114
Drug: 600 ml
RxNorm normalized name: urinary bag 600 mL-10" MISCELL EACH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 ml of water (W)
Trial: 22692114
Drug: Carbohydrate-electrolyte solution
RxNorm normalized name: CARBOHYDRATE/ELECTROLYTES
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carbohydrate-electrolyte solution with 3% or light carbohydrate (CES-L, 20 mM Na)
Trial: 22692114
Drug: Carbohydrate-electrolyte solution
RxNorm normalized name: CARBOHYDRATE/ELECTROLYTES
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carbohydrate-electrolyte solution with 6% carbohydrate (CES, 20 mM Na)
Trial: 20071896
Drug: Music therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Music therapy and rhythmic exercise (twice a week for 8 weeks)
Trial: 9022524
Drug: Aspartame treatment
RxNorm normalized name: Aspartame
DrugBank: Aspartame (DB00168)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspartame treatment group
Trial: 9022524
Drug: No aspartame
RxNorm normalized name: Aspartame
DrugBank: Aspartame (DB00168)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No aspartame treatment group
Trial: 3510822
Drug: Oxitropium bromide
RxNorm normalized name: oxitropium bromide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxitropium bromide (200 micrograms) and fenoterol (400 micrograms) combination
Trial: 30710391
Drug: CEP-26401 (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CEP-26401 (5 μg)
Trial: 30710391
Drug: CEP-26401 (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CEP-26401 (25 μg)
Trial: 30710391
Drug: CEP-26401 (125
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CEP-26401 (125 μg)
Trial: 26865535
Drug: Glipizide (≤20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glipizide (≤20 mg daily)
Trial: 17931408
Drug: Cocaine (0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cocaine (0.2 mg/kg) administered under 100% probability ('unblinded')
Trial: 17931408
Drug: Cocaine (0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cocaine (0.2 mg/kg) administered under 33% probability ('blinded')
Trial: 10839761
Drug: Azithromycin treatment
RxNorm normalized name: Azithromycin
DrugBank: Azithromycin (DB00207)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Azithromycin treatment for 3 months
Trial: 9286227
Drug: Ethanol-containing solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ethanol-containing solution (4% w/v, 4.06 kcal/min, 1190 mosmol/kg)
Trial: 9286227
Drug: Ethanol-free solution
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ethanol-free solution (2.64 kcal/min, 160 mosmol/kg)
Trial: 9286227
Drug: Ethanol-free hyperosmolar
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ethanol-free hyperosmolar solution (4.06 kcal/min, 1160 mosmol/kg)
Trial: 24800966
Drug: Web-based guided
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Web-based guided self-help course (Happy@Work), 6 weekly lessons
Trial: 22418581
Drug: Antibiotic-impregnated EVD
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Antibiotic-impregnated EVD catheters
Trial: 15590212
Drug: Transdermal estradiol
RxNorm normalized name: estradiol Transdermal System
DrugBank: Estradiol (DB00783)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal estradiol therapy (50 microg per day) for 3 months
Trial: 10100650
Drug: Single treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single treatment IPL
Trial: 10100650
Drug: Double treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Double treatment IPL
Trial: 8728345
Drug: Intravenous administration
RxNorm normalized name: intravenous administration set
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous administration of mycophenolate mofetil (1.5 g)
Trial: 8728345
Drug: Oral administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral administration of mycophenolate mofetil (1.5 g)
Trial: 8728345
Drug: Both routes
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both routes (oral and intravenous)
Trial: 6344625
Drug: 1,000 mg
RxNorm normalized name: bran 1,000 mg ORAL WAFER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1,000 mg acetaminophen
Trial: 29020251
Drug: Celecoxib (100-200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Celecoxib (100-200 mg bid)
Trial: 29020251
Drug: Ibuprofen (600-800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen (600-800 mg tid)
Trial: 29020251
Drug: Naproxen (375-500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naproxen (375-500 mg bid)
Trial: 19950736
Drug: Microcurrent skin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Microcurrent skin patches (two adhesive electrodes)
Trial: 19950736
Drug: Continuous epidural
RxNorm normalized name: ACCU-BLOC PERIFIX CONTINUOUS EPIDURAL ANESTHESIA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous epidural infusion with fentanyl (Control Group)
Trial: 17518957
Drug: Profylin fluoride
RxNorm normalized name: Hydrogen fluoride
DrugBank: Hydrogen fluoride (DB11072)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Profylin fluoride gel with buffering components
Trial: 17518957
Drug: Profylin fluoride
RxNorm normalized name: Hydrogen fluoride
DrugBank: Hydrogen fluoride (DB11072)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Profylin fluoride gel without buffering components
Trial: 27618821
Drug: Genexol-PM 260
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Genexol-PM 260 mg/m2
Trial: 27618821
Drug: Genexol 175
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Genexol 175 mg/m2
Trial: 23890047
Drug: Evening administration
RxNorm normalized name: Evenity
DrugBank: Romosozumab (DB11866)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Evening administration of low-dose aspirin
Trial: 21773673
Drug: Travoprost 0.004%/timolol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Travoprost 0.004%/timolol 0.5% fixed combination (TTFC)
Trial: 19384192
Drug: Valsartan/HCTZ (160
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valsartan/HCTZ (160 mg/25 mg, titrated to 320/25 mg)
Trial: 19384192
Drug: Amlodipine/HCTZ (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amlodipine/HCTZ (5 mg/25 mg, titrated to 10/25 mg)
Trial: 17107398
Drug: Lactobacillus rhamnosus
RxNorm normalized name: Lactobacillus Rhamnosus
DrugBank: Lacticaseibacillus rhamnosus (DB19282)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lactobacillus rhamnosus (LGG) 10 x 10^9 colony-forming units daily for 8 weeks
Trial: 15902479
Drug: 2-hourly clamping
RxNorm normalized name: benzalkonium
DrugBank: Benzalkonium (DB11105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 2-hourly clamping of drain and release for 10 min
Trial: 10687944
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg PPA
Trial: 10687944
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg PPA
Trial: 10687944
Drug: PPA (both
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PPA (both doses)
Trial: 6130599
Drug: Antacid tablets
RxNorm normalized name: Calcium Carbonate 500 MG Oral Tablet, Chewable [GOOD SENSE ANTACID TABLETS]
DrugBank: Dimethicone (DB11074)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Antacid tablets (total acid‐neutralizing capacity, 280 mmol/day)
Trial: 6130599
Drug: Antacid tablets
RxNorm normalized name: Calcium Carbonate 500 MG Oral Tablet, Chewable [GOOD SENSE ANTACID TABLETS]
DrugBank: Dimethicone (DB11074)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Antacid tablets
Trial: 26926659
Drug: Problem solving
RxNorm normalized name: Solv X
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Problem solving therapy (PST)
Trial: 30343455
Drug: All three
RxNorm normalized name: three-lobe sage extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: All three therapies
Trial: 24411921
Drug: Tipifarnib 300
RxNorm normalized name: Tipifarnib
DrugBank: Tipifarnib (DB04960)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tipifarnib 300 mg orally twice daily on days 1‐21
Trial: 24411921
Drug: Tipifarnib 600
RxNorm normalized name: Tipifarnib
DrugBank: Tipifarnib (DB04960)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tipifarnib 600 mg orally twice daily on days 1‐21
Trial: 24411921
Drug: Tipifarnib 300
RxNorm normalized name: Tipifarnib
DrugBank: Tipifarnib (DB04960)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tipifarnib 300 mg orally twice daily on days 1‐7 and 15‐21
Trial: 24411921
Drug: Tipifarnib 600
RxNorm normalized name: Tipifarnib
DrugBank: Tipifarnib (DB04960)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tipifarnib 600 mg orally twice daily on days 1‐7 and 15‐21
Trial: 23160054
Drug: School Well-Being
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: School Well-Being Therapy intervention
Trial: 15713438
Drug: Chlorinated solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlorinated solution of neutral red with ultraviolet-A light exposure
Trial: 12589898
Drug: Psychological treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Psychological treatments for prodromal symptoms
Trial: 11149790
Drug: Dexamethasone (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone (10 mg) preoperatively
Trial: 11149790
Drug: Dexamethasone (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone (10 mg) postoperatively
Trial: 11149790
Drug: Dexamethasone (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone (10 mg) preoperatively or postoperatively
Trial: 27757820
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (occupational therapy)
Trial: 25308787
Drug: Biweekly induction
RxNorm normalized name: Biweekly Transdermal Patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Biweekly induction with intravitreal bevacizumab (every 2 weeks for 3 consecutive injections)
Trial: 25308787
Drug: Monthly induction
RxNorm normalized name: tobramycin
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Monthly induction with intravitreal bevacizumab (every 4 weeks for 3 consecutive injections)
Trial: 25308787
Drug: Immediate pro
RxNorm normalized name: Climara Pro
DrugBank: Estradiol (DB00783)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Immediate pro re nata (prn) after the first injection
Trial: 24180715
Drug: Total intravenous
RxNorm normalized name: Colgate Total Mouthwash
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Total intravenous anaesthesia (TIVA) using propofol plus remifentanil